Table 3.
DRUGS | AGING* | AD** | AMD | CANCER | CDV | FRAILTY | MET.S** | OSTEOA | OSTEOP | PD | SARCOPENIA | T2D*** |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ACARBOSE | 2 | 0 | 0 | 4 | 19 | 0 | 1 | 0 | 0 | 0 | 0 | 67 |
ASPIRIN | 1 | 0 | 3 | 161 | 1008 | 0 | 3 | 2 | 0 | 0 | 0 | 53 |
CURCUMIN | 9 | 5 | 0 | 65 | 8 | 0 | 7 | 4 | 0 | 0 | 0 | 8 |
GDF8 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 |
GREEN TEA | 5 | 0 | 0 | 97 | 31 | 0 | 2 | 1 | 1 | 1 | 0 | 17 |
METFORMIN | 11 | 3 | 1 | 335 | 105 | 4 | 62 | 0 | 0 | 0 | 1 | 1337 |
METHYLENE BLUE | 1 | 7 | 0 | 43 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAD_NAD precursors | 12 | 2 | 0 | 13 | 57 | 1 | 9 | 0 | 0 | 0 | 2 | 9 |
POLYAMINES | 1 | 2 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
QUERCETIN | 2 | 1 | 0 | 13 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
RAPAMYCIN | 11 | 0 | 12 | 1106 | 473 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
RESVERATROL | 10 | 5 | 2 | 15 | 10 | 0 | 13 | 1 | 2 | 6 | 1 | 15 |
SRT2104 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 7 |
SRT3025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
SIMVASTATIN | 1 | 8 | 0 | 58 | 172 | 0 | 14 | 0 | 1 | 1 | 0 | 42 |
TRYPTOPHAN | 0 | 2 | 0 | 3 | 9 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
INTERVENTIONS | ||||||||||||
CALORIC RESTRICTION | 15 | 7 | 0 | 57 | 20 | 0 | 22 | 3 | 0 | 0 | 0 | 31 |
EXERCISE | 435 | 167 | 0 | 1214 | 1979 | 80 | 229 | 331 | 93 | 179 | 121 | 628 |
FASTING | 20 | 21 | 2 | 281 | 240 | 0 | 50 | 15 | 12 | 22 | 4 | 339 |
KETOGENIC DIET | 0 | 9 | 0 | 26 | 4 | 0 | 2 | 0 | 0 | 2 | 0 | 7 |
TOTAL | 538 | 239 | 20 | 3496 | 4141 | 85 | 414 | 357 | 109 | 212 | 134 | 2564 |
Includes age, aging and longevity.
Includes Alzheimer’s disease, dementia and mild cognitive impairment; AD (Alzheimer’s disease); CDV (cardiovascular disease); Met.S (metabolic syndrome); Osteoa (osteoarthritis); Osteop (osteoporosis); PD (Parkinson’s disease); T2D (type 2 diabetes).